BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 32624034)

  • 1. Risk factors and outcomes of patients colonized with carbapenemase-producing and non-carbapenemase-producing carbapenem-resistant
    Kassem A; Raed A; Michael T; Sagi O; Shimoni O; Borer A; Saidel-Odes L
    Infect Control Hosp Epidemiol; 2020 Oct; 41(10):1154-1161. PubMed ID: 32624034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for acquisition of carbapenemase-producing versus non-carbapenemase-producing enterobacterales: a case-control study.
    Hassoun-Kheir N; Hussein K; Karram M; Saffuri M; Badaan S; Peleg S; de Kraker MEA; Aboelhega W; Warman S; Alon T; Eluk O; Geffen Y; Paul M
    Clin Microbiol Infect; 2023 May; 29(5):629-634. PubMed ID: 36641053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiological Characteristics of Carbapenemase Producing Carbapenem-Resistant Enterobacteriaceae Colonization.
    Jeong IS; Song JY
    Asian Nurs Res (Korean Soc Nurs Sci); 2022 Aug; 16(3):134-139. PubMed ID: 35605957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk Factors for Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae (CP-CRE) Acquisition Among Contacts of Newly Diagnosed CP-CRE Patients.
    Schwartz-Neiderman A; Braun T; Fallach N; Schwartz D; Carmeli Y; Schechner V
    Infect Control Hosp Epidemiol; 2016 Oct; 37(10):1219-25. PubMed ID: 27452597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing the Outcomes of Patients With Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae Bacteremia.
    Tamma PD; Goodman KE; Harris AD; Tekle T; Roberts A; Taiwo A; Simner PJ
    Clin Infect Dis; 2017 Feb; 64(3):257-264. PubMed ID: 28013264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Factors and Molecular Epidemiology of Complicated Intra-Abdominal Infections With Carbapenem-Resistant Enterobacteriaceae: A Multicenter Study in China.
    Liu J; Zhang L; Pan J; Huang M; Li Y; Zhang H; Wang R; Zhao M; Li B; Liu L; Gong Y; Bian J; Li X; Tang Y; Lei M; Chen D
    J Infect Dis; 2020 Mar; 221(Suppl 2):S156-S163. PubMed ID: 32176797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Likelihood of Developing a Carbapenem-Resistant
    Tamma PD; Kazmi A; Bergman Y; Goodman KE; Ekunseitan E; Amoah J; Simner PJ
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31138574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk Factors Associated With Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae Positive Cultures in a Cohort of US Veterans.
    Wilson GM; Suda KJ; Fitzpatrick MA; Bartle B; Pfeiffer CD; Jones M; Rubin MA; Perencevich E; Evans M; Evans CT;
    Clin Infect Dis; 2021 Oct; 73(8):1370-1378. PubMed ID: 33973631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing mortality in patients with carbapenemase-producing carbapenem resistant Enterobacterales and non-carbapenemase-producing carbapenem resistant Enterobacterales bacteremia.
    Hovan MR; Narayanan N; Cedarbaum V; Bhowmick T; Kirn TJ
    Diagn Microbiol Infect Dis; 2021 Dec; 101(4):115505. PubMed ID: 34399381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment and Outcomes of Infections Caused by Diverse Carbapenemase-Producing Carbapenem-Resistant
    Lim FK; Liew YX; Cai Y; Lee W; Teo JQM; Lay WQ; Chung J; Kwa ALH
    Front Cell Infect Microbiol; 2020; 10():579462. PubMed ID: 33178629
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of Double-Carbapenem Regimen in the Treatment of Infections due to Carbapenemase Producing Carbapenem-Resistant
    Cancelli F; Oliva A; De Angelis M; Mascellino MT; Mastroianni CM; Vullo V
    Biomed Res Int; 2018; 2018():2785696. PubMed ID: 30581848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency of and risk factors for carbapenem-resistant
    Barber KE; Wagner JL; Larry RC; Stover KR
    J Med Microbiol; 2021 Feb; 70(2):. PubMed ID: 33263511
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical Risk Factors and Microbiological and Intestinal Characteristics of Carbapenemase-Producing
    Yuan W; Xu J; Guo L; Chen Y; Gu J; Zhang H; Yang C; Yang Q; Deng S; Zhang L; Deng Q; Wang Z; Ling B; Deng D
    Microbiol Spectr; 2022 Dec; 10(6):e0190621. PubMed ID: 36445086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of intestinal carriage of carbapenem-resistant Enterobacteriaceae among inpatients at two Iranian university hospitals: first report of co-production of bla
    Solgi H; Badmasti F; Aminzadeh Z; Giske CG; Pourahmad M; Vaziri F; Havaei SA; Shahcheraghi F
    Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2127-2135. PubMed ID: 28639165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical characteristics of carbapenem-resistant
    Sun Y; Zheng H; Zhang JL; Yu LX; Wang B; Gao W; Cai JZ; Liu YH
    Zhonghua Er Ke Za Zhi; 2020 Aug; 58(8):640-645. PubMed ID: 32842384
    [No Abstract]   [Full Text] [Related]  

  • 16. Screening of nursing home residents for colonization with carbapenem-resistant Enterobacteriaceae admitted to acute care hospitals: Incidence and risk factors.
    Cunha CB; Kassakian SZ; Chan R; Tenover FC; Ziakas P; Chapin KC; Mermel LA
    Am J Infect Control; 2016 Feb; 44(2):126-30. PubMed ID: 26631643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation on the transmission rate of carbapenemase-producing carbapenem-resistant Enterobacterales among exposed persons in a tertiary hospital using whole-genome sequencing.
    Chang E; Chang HE; Shin IS; Oh YR; Kang CK; Choe PG; Park WB; Choi EH; Oh MD; Park KU; Kim NJ
    J Hosp Infect; 2022 Jun; 124():1-8. PubMed ID: 35307505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbapenem-resistant Enterobacteriaceae in patients with bacteraemia at tertiary hospitals in South Africa, 2015 to 2018.
    Perovic O; Ismail H; Quan V; Bamford C; Nana T; Chibabhai V; Bhola P; Ramjathan P; Swe Swe-Han K; Wadula J; Whitelaw A; Smith M; Mbelle N; Singh-Moodley A;
    Eur J Clin Microbiol Infect Dis; 2020 Jul; 39(7):1287-1294. PubMed ID: 32124106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicenter Study of the Risk Factors for Colonization or Infection with Carbapenem-Resistant Enterobacteriaceae in Children.
    Chiotos K; Tamma PD; Flett KB; Naumann M; Karandikar MV; Bilker WB; Zaoutis T; Han JH
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for carbapenem-resistant Enterobacteriaceae infections: a French case-control-control study.
    Nicolas-Chanoine MH; Vigan M; Laouénan C; Robert J;
    Eur J Clin Microbiol Infect Dis; 2019 Feb; 38(2):383-393. PubMed ID: 30488368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.